FDA Recommendation Sends Edwards Lifesciences Shares Higher

Cardiovascular device maker Edwards Lifesciences (EW) rose 7% on news that a Food and Drug Administration panel had recommended approval of its SAPIEN transcatheter heart valve for wider usage. The FDA voted 11 to 0 with one abstention to approve the device for high risk patients with the condition symptomatic aortic stenosis. “We are very [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.